COVID CommUNITY - First Nations Investigating Vaccine Access, Immunogenicity, Effectiveness and Safety among High-Risk Populations (First Nations) [Funder: PHRI]
- Funded by Other Funders (Canada)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Other Funders (Canada)Principal Investigator
Sonia and Shrikant and Russell and Dipika and Jodi Anand and Bangdiwala and De Souza and Desai and MillerResearch Location
CanadaLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Indigenous People
Occupations of Interest
Unspecified
Abstract
The COVID CommUNITY - First Nations study is being conducted to understand the immune response and safety of the COVID-19 vaccine in First Nations people who have been disproportionately affected by the pandemic, and have worse outcomes from COVID-19 infection compared to other groups. The study also aims to understand why some people are not as confident in the COVID-19 vaccine as others, and to document the overall impact of COVID-19 in these communities. The study will also provide insight into how a pandemic of this scale can be prevented in these communities and other vulnerable populations. Participants for the study are being recruited from First Nations communities: i From vaccination or assessment centres and; ii By re-contacting participants (18+) from our on-going prospective cohort studies via telephone/email. Dried blood spots for assessment of antibodies to COVID vaccination are being assessed from all participants.